Skip to main content
. 2021 Dec 5;10(23):5705. doi: 10.3390/jcm10235705

Figure 2.

Figure 2

Images of representative eyes exhibiting submacular hemorrhage after vaccination. (A–D), Fundus photographs of eyes 1 and 2 before and after symptom exacerbation. This AMD patient developed subretinal hemorrhage in both eyes (A,B). Three days after the first dose of BNT162b2 and 1 week after photographs A and B were taken, the patient developed blurred vision, and fundus photographs taken on the following day revealed that the hemorrhage in both eyes had worsened (C,D). (E,F), Fundus photographs of eye 10 taken 4 weeks before and after symptom exacerbation. Two days after ChADOx1 vaccination, the patient experienced visual disturbance, and fundus photography revealed a new submacular hemorrhage. (G,H), Fundus and wide-angle fundus photographs of eye 4 taken 7 weeks before and after symptom exacerbation. The patient experienced reduced visual acuity 6 days after the first dose of BNT162b2; a massive submacular hemorrhage was evident.